Bin Peng

23.1k citations
219 papers · 10.3k · 4 hit papers · h-index 41

Impact in

  • Hematology top 0.1%
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.2%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Ischemic Stroke Management 31
    • Autoimmune Neurological Disorders and Treatments 12
    • Intracerebral and Subarachnoid Hemorrhage Research 8

Bin Peng

208 papers receiving 10.1k citations

Bin Peng's Hit Papers

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor–Dysregulated Non–Small-Cell Lung Cancer 2018 · 251 citations
2510+8+16Years since publication10002.0k3.0k

Peers

Bin Peng
Comparison fields: 5 of 159
  • Hematology 3.6k
  • Genetics 2.2k
  • Neurology 1.5k
  • Rheumatology 1.5k
  • Gastroenterology 507
Replace Serge Leyvraz with:
Serge Leyvraz Switzerland
Pierre Ronco France
Martee L. Hensley United States
Sergio Amadori Italy
Carlos E. Bueso‐Ramos United States
Maher Albitar United States
Brigitte C. Widemann United States
Achille Iolascon Italy
Stanley Cohen United States
Keith R. McCrae United States
Bin Peng relative to Serge Leyvraz Switzerland Serge Leyvraz's profile →
Citations per field
00.5×5.2×
Serge Leyvraz · 1×
Citations per year

Countries citing papers authored by Bin Peng

Since Specialization
Citations

This map shows the geographic impact of Bin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Peng more than expected).

Fields of papers citing papers by Bin Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Peng. The network helps show where Bin Peng may publish in the future.

Co-authors

The 25 scholars most cited alongside Bin Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bin Peng Line = papers co-authored together Bin Peng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Hit paper breakdown →
20013828
2
Clinical Pharmacokinetics of Imatinib
Hit paper breakdown →
2005518
3
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial
Hit paper breakdown →
2008513
4 2004374
5
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor–Dysregulated Non–Small-Cell Lung Cancer
Hit paper breakdown →
2018251
6 2010192
7 2005187
8 2004173
9 2010172
10 2004159
11 2011146
12 2009133
13 2004131
14 2004126
15 2004122
16 2011120
17
Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis.
2015118
18 2019112
19 2005106
20 201794

About Bin Peng

Bin Peng is a scholar working on Epidemiology, Neurology, Molecular Biology, Pulmonary and Respiratory Medicine and Hematology, having authored 219 papers that have together received 10.3k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (31 papers), Cerebrovascular and Carotid Artery Diseases (14 papers), Autoimmune Neurological Disorders and Treatments (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), Multiple Sclerosis Research Studies (11 papers), Natural Compounds in Disease Treatment (10 papers), Intracerebral and Subarachnoid Hemorrhage Research (8 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Hematology (3.6k citations), Genetics (2.2k citations), Neurology (1.5k citations), Rheumatology (1.5k citations) and Gastroenterology (507 citations). Bin Peng has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Renaud Capdeville, J. Ford, Brian Druker, Moshe Talpaz, Debra Resta, Charles L. Sawyers, Nicholas Lydon, Hagop M. Kantarjian, Elisabeth Buchdunger and Sayuri Ohno-Jones. Their work appears in journals such as Frontiers in Neurology, BMC Neurology, Journal of Clinical Oncology, Journal of Stroke and Cerebrovascular Diseases and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact